| Literature DB >> 32370590 |
Qing Lv1,2, Wei Sun1,2, Jing Wang1,2, Chun Wu1,2, He Li1,2, Xuehua Shen3, Bo Liang3, Nianguo Dong4, Yuman Li1,2, Li Zhang1,2, Mingxing Xie1,2.
Abstract
Background The current study aims to validate the accuracy of 3-dimensional speckle-tracking echocardiography (3D-STE) in evaluating biventricular functions against the accuracy of cardiac magnetic resonance (CMR) and to explore the comprehensive characteristics and normal values for 3D-biventricular functions in transplanted hearts. Methods and Results A cohort of 35 heart transplant (HT) patients underwent both 3D echocardiography and CMR examination to validate the accuracy of 3D-STE in evaluating biventricular functions (Protocol 1). Then, 3D-STE derived biventricular functions were compared between 46 HT patients and 46 non-HT controls (Protocol 2). Protocol 1, validated that 3D-STE showed excellent accuracy in evaluating biventricular functions of transplanted hearts against CMR. Protocol 2, revealed lower (normal range) 3D-biventricular ejection fractions in HT patients than in controls (P<0.001). 3D-left ventricular global longitudinal strain, left ventricular-global circumferential strain, left ventricular-global radial strain, left ventricular-global performance index and right ventricular free-wall longitudinal strain were all lower in the HT patients than in healthy controls (P<0.001). Further, these strain values were all good for differentiating between groups (areas under the curve: 0.80-0.94, P<0.001). Moreover, left ventricular-lateral-wall radial displacement was higher and septal-wall radial displacement was lower in the HT group than in control group (P<0.001). Conclusions Compared with cardiac magnetic resonance, 3D-STE can evaluate biventricular functions of transplanted hearts accurately; 3D-biventricular mechanical functions are reduced even in clinically well HT patients. The provided characteristics and appropriate normal values of biventricular functions can be the basis for detection of ventricular dysfunction during follow-ups and further studies on transplanted hearts.Entities:
Keywords: 3‐dimensional speckle‐tracking echocardiography; biventricular function; cardiac magnetic resonance; heart transplant; myocardial strain
Mesh:
Year: 2020 PMID: 32370590 PMCID: PMC7660853 DOI: 10.1161/JAHA.119.015742
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Clinical Characteristics of the 46 HT Recipients
| Parameter | Value |
|---|---|
| Pre‐HT | |
| Etiology for transplant | |
| Dilated cardiomyopathy | 24 (52%) |
| Hypertrophic cardiomyopathy | 3 (7%) |
| Ischemic cardiomyopathy | 6 (13%) |
| Valvular/rheumatic heart disease | 4 (9%) |
| Complex congenital heart disease | 3 (7%) |
| Restrictive cardiomyopathy | 1 (2%) |
| Other diseases | 5 (11%) |
| Donor age at HT, y | 33±11 |
| Recipient age at HT, y | 46±13 |
| Invasive sPAP, mm Hg | 55±18 |
| Invasive mPAP, mm Hg | 37±12 |
| Parameters at echocardiographic examination | |
| Time since HT, y | 1.0±0.1 |
| Systolic blood pressure, mm Hg | 120±8 |
| Diastolic blood pressure, mm Hg | 81±9 |
| Comorbidities | |
| Hypertension | 22 (49%) |
| Diabetes mellitus | 21 (46%) |
Data are expressed as mean±SD or as number (%). HT indicates heart transplant; mPAP, mean pulmonary artery pressure; and sPAP, systolic pulmonary artery pressure.
General Information and 2‐Dimensional Echocardiographic Measurements of HT Group and Control Group
| Parameter | HT Group (n=46) | Control Group (n=46) |
|
|---|---|---|---|
| Men (%) | 36 (78%) | 34 (74%) | 0.625 |
| Age, y | 46±13 | 45±13 | 0.538 |
| Height, cm | 168±7 | 168±7 | 0.829 |
| Weight, kg | 68±13 | 67±10 | 0.778 |
| BSA, m2 | 1.7±0.2 | 1.7±0.2 | 0.970 |
| HR, bpm | 89±9 | 68±11 | <0.001 |
| SBP, mm Hg | 119±9 | 117±7 | 0.284 |
| DBP, mm Hg | 79±9 | 76±8 | 0.203 |
| Left ventricle | |||
| LVEF, % | 64±5 | 68±4 | <0.001 |
| Bicuspid E, m/s | 0.9±0.2 | 0.8±0.1 | 0.004 |
| Bicuspid A, m/s | 0.5±0.1 | 0.7±0.2 | <0.001 |
| Bicuspid E/A ratio | 1.8±0.4 | 1.2±0.4 | <0.001 |
| Bicuspid e’, cm/s | 11±2 | 12±3 | 0.519 |
| Bicuspid E/e’ | 8±3 | 7±2 | 0.016 |
| Bicuspid DT, ms | 172±33 | 205±38 | <0.001 |
| Right ventricle | |||
| FAC, % | 44±4 | 50±4 | <0.001 |
| TAPSE, mm | 16±3 | 24±2 | <0.001 |
| Tricuspid S’, cm/s | 11±3 | 13±2 | <0.001 |
| Tricuspid E, m/s | 0.6±0.1 | 0.5±0.1 | 0.072 |
| Tricuspid e’, cm/s | 10±3 | 11±3 | 0.047 |
| Tricuspid E/e’ | 7±3 | 5±2 | 0.003 |
Data are expressed as mean±SD; P<0.05 was considered statistically significant. BSA indicates body surface area; DBP, diastolic blood pressure; DT, deceleration time of E; FAC, fractional area change; HR, heart rate; HT, heart transplant; LVEF, left ventricular ejection fraction; SBP, systolic blood pressure; and TAPSE, tricuspid annular plane systolic excursion.
Three‐Dimensional Speckle‐Tracking Echocardiographic Measurements of HT Group and Control Group
| Parameter | HT Group (n=46) | Control Group (n=46) |
|
|---|---|---|---|
| Left ventricle | |||
| LVEF, % | 62.5±4.4 | 67.8±4.1 | <0.001 |
| GS, % | −37.2±4.3 | −41.3±4.0 | <0.001 |
| GLS, % | −17.2±1.3 | −20.8±1.7 | <0.001 |
| GCS | −31.9±4.3 | −36.8±4.0 | <0.001 |
| GRS | 40.7±4.0 | 48.1±4.1 | <0.001 |
| Radial displacement, mm | |||
| Septal | 3.7±1.6 | 7.2±1.4 | <0.001 |
| Lateral | 8.4±2.0 | 6.2±1.1 | <0.001 |
| Twist, ° | 13.3±5.2 | 18.2±5.5 | <0.001 |
| Torsion, °/cm | 1.9±0.8 | 2.4±0.8 | 0.001 |
| SDI, % | 7.9±2.2 | 5.0±1.6 | <0.001 |
| GPI, °/cm | −10.4±7.5 | −22.0±10.9 | <0.001 |
| Right ventricle | |||
| RVEF, % | 46.0±3.7 | 47.8±3.0 | 0.011 |
| RV FWLS, % | −18.7±1.6 | −22.1±2.0 | <0.001 |
Data are expressed as mean±SD; P<0.05 was considered statistically significant. FWLS indicates free wall longitudinal strain; GCS, global circumferential strain; GLS, global longitudinal strain; GPI, global performance index; GRD, global radial strain; GS, global peak systolic strain; HT, heart transplant; LVEF, left ventricular ejection fraction; RVEF, right ventricular ejection fraction; and SDI, systolic dyssynchrony index.
vs septal radial displacement, P<0.05.
Figure 1Representative images for the comparison of biventricular mechanical function in a heart transplant recipient and a healthy control by 3‐dimensional speckle‐tracking echocardiography.
Three‐dimensional speckle‐tracking echocardiography images for the reduced (A) left ventricular global longitudinal strain, (B) left ventricular global circumferential strain, (C) left ventricular global radial strain, and (D) right ventricular free wall longitudinal strain in a heart transplant recipient than that in healthy controls. 3D‐STE indicates 3‐dimensional speckle‐tracking echocardiography; HT, heart transplant; LV GCS, left ventricular global circumferential strain; LV GLS, left ventricular global longitudinal strain; LV GRS, left ventricular global radial strain; and RV FWLS, right ventricular free wall longitudinal strain.
Figure 2Receiver operating characteristic analysis for left ventricular (LV) global longitudinal strain, LV global circumferential strain, LV global radial strain, LV global performance index, and right ventricular free wall longitudinal strain.
The area under the curve, best cutoff values, corresponding sensitivity, and the specificity for LV global longitudinal strain, LV global circumferential strain, LV global radial strain, LV global performance index, right ventricular free wall longitudinal strain are shown in the table below. AUC indicates area under the curve; LV GCS, left ventricular global circumferential strain; LV GLS, left ventricular global longitudinal strain; LV GPI, left ventricular global performance index; LV GRS, left ventricular global radial strain; and RV FWLS, right ventricular free wall longitudinal strain. Dashed lines representing 95% CI.
Inter‐Observer and Intra‐Observer Reproducibility for the Parameters of 3‐Dimensional Speckle‐Tracking Echocardiography
| ICC (95% CI) | Bias | LOA | |
|---|---|---|---|
| Inter‐observer (n=15) | |||
| 3D‐LVEF (%) | 0.97 (0.93–0.99) | −0.1 | ±2.4 |
| 3D‐RVEF (%) | 0.92 (0.72–0.98) | −1.3 | ±2.4 |
| 3D‐LV GLS (%) | 0.85 (0.66–0.95) | −0.7 | ±1.5 |
| 3D‐LV GCS (%) | 0.92 (0.79–0.97) | 0.3 | ±3.9 |
| 3D‐LV GRS (%) | 0.93 (0.81–0.98) | 0.3 | ±3.7 |
| 3D‐RV FWLS (%) | 0.86 (0.82–0.98) | −0.9 | ±2.7 |
| CMR‐LVEF (%) | 0.96 (0.86–0.99) | −1.1 | ±3.4 |
| CMR‐RVEF (%) | 0.93 (0.81–0.98) | 0.5 | ±4.1 |
| Intra‐observer (n=15) | |||
| 3D‐LVEF (%) | 0.98 (0.94–0.99) | 0.3 | ±1.6 |
| 3D‐RVEF (%) | 0.95 (0.86–0.98) | 0.1 | ±2.7 |
| 3D‐LV GLS (%) | 0.88 (0.70–0.96) | 0.7 | ±0.9 |
| 3D‐LV GCS (%) | 0.96 (0.89–0.99) | 0.1 | ±2.2 |
| 3D‐LV GRS (%) | 0.97 (0.90–0.99) | −0.1 | ±2.1 |
| 3D‐RV FWLS (%) | 0.95 (0.85–0.98) | 0.1 | ±1.9 |
| CMR‐LVEF (%) | 0.98 (0.91–0.99) | 0.9 | ±1.9 |
| CMR‐RVEF (%) | 0.96 (0.89–0.99) | 0.4 | ±2.9 |
3D indicates 3‐dimensional; CMR, cardiac magnetic resonance; ICC, intra‐class correlation coefficients; LOA, limits of agreement; LVEF, left ventricular ejection fraction; LV GCS, left ventricular global circumferential strain; LV GLS, left ventricular global longitudinal strain; LV GRS, left ventricular global radial strain; RV FWLS, right ventricular free wall longitudinal strain; and RVEF, right ventricular ejection fraction.